| Filed On | Filing |
|---|---|
| 06 Jul 2026 |
Form 3: Qiu Min, Chief Executive Officer
Holds 2,498 shares of Ordinary Shares |
| 06 Jul 2026 |
Form 3: Li Na (NL), Chief Financial Officer
No securities owned |
| 11 Aug 2025 |
Form 3: Decheng Capital China Life Sciences Usd Fund III, L.p., 10% owner and 5 others
Holds 1,979,072 shares of Ordinary Shares |
| 31 Dec 2024 | Form 3: Xu Sihai, Director |
| 31 Dec 2024 |
Form 3: Majeti Jiangwen, Director
Holds 50,914 shares of Ordinary Shares |
| 31 Dec 2024 |
Form 3: Lu Yingjuan June, Chief Scientific Officer
Holds 100 shares of Ordinary Shares |
| 31 Dec 2024 | Form 3: Delaney Brendan, Director |
| 31 Dec 2024 |
Form 3: Fabbio Patrick, Director
Holds 24,592 shares of Ordinary Shares |
| 31 Dec 2024 | Form 3: Kirkby Matthew, Director |
| 31 Dec 2024 |
Form 3: Huang Lan, Director
Holds 2 shares of Ordinary Shares |
Loading...
